BackSio Gene Therapies Overview

Sio Gene Therapies Accounts Payable

Latest accounts payable for SIOX: $200K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$201000.00
↓ 96.96% YoYΔ $-6.41M vs prior year quarter

Peer trimmed avg / median

Loading

Sio Gene Therapies Accounts Payable History

Loading

Sio Gene Therapies vs. peers: Accounts Payable Comparison

Loading

Sio Gene Therapies Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sio Gene Therapies (SIOX) FAQ

As of the most recent data (December 2022), SIOX shows a accounts payable of $200K. That compares with $6.6M in the prior-year period — down 97.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SIOX's accounts payable is now $200K (was $6.6M) — a 97.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sio Gene Therapies is outperforming or lagging.

Tracking SIOX's accounts payable over time shows whether Sio Gene Therapies is scaling, shrinking, or reshaping that part of the business. The current reading is $200K That compares with $6.6M in the prior-year period — down 97.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Sio Gene Therapies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $200K) with ownership activity and broader fundamentals.

Sio Gene Therapies's accounts payable is $200K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.